Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*

Infectious Diseases Society of America

1969 • 2,591 citations

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

2002 • 973 citations

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

2005 • 965 citations

Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

2005 • 661 citations

Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*

2002 • 564 citations

Risk factors for hospital-acquired candidemia. A matched case-control study

1989 • 520 citations

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

2002 • 515 citations

CD4 Counts as Predictors of Opportunistic Pneumonias in Human Immunodeficiency Virus (HIV) Infection

1989 • 504 citations

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy

1998 • 444 citations

Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole

2004 • 405 citations

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome

2003 • 390 citations

Practice Guidelines for the Management of Patients with Histoplasmosis

2000 • 377 citations

Results of the Fludarabine and Cyclophosphamide Combination Regimen in Chronic Lymphocytic Leukemia

2001 • 362 citations

Risk Factors for Hospital-Acquired Candidemia

1989 • 337 citations

Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received Fludarabine

2002 • 318 citations

Guidelines for preventing opportunistic infections among HIV-infected persons

2002 • 318 citations

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

2000 • 314 citations

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

2001 • 309 citations

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

2004 • 309 citations

Infections in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine

1998 • 304 citations

Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons--2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America

2002 • 274 citations

Practice Guidelines for the Treatment of Coccidioidomycosis

2000 • 274 citations

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

2004 • 273 citations

Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H

1998 • 264 citations

Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia

2003 • 230 citations

T‐Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review

2000 • 218 citations

Infections Complicating Mycosis Fungoides and Sézary Syndrome

1992 • 211 citations

Practice Guidelines for the Management of Patients with Blastomycosis

2000 • 208 citations

Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.

1994 • 199 citations

Towards a targeted, risk‐based, antifungal strategy in neutropenic patients

2000 • 188 citations

Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection

2000 • 185 citations

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

2003 • 169 citations

Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention.

2003 • 158 citations

Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection

2005 • 157 citations

Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

2004 • 156 citations

Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.

2002 • 147 citations

Impact of Therapy With Chlorambucil, Fludarabine, or Fludarabine Plus Chlorambucil on Infections in Patients With Chronic Lymphocytic Leukemia: Intergroup Study Cancer and Leukemia Group B 9011

2001 • 144 citations

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

2003 • 143 citations

High Rates of Pneumocystis carinii Pneumonia in Allogeneic Blood and Marrow Transplant Recipients Receiving Dapsone Prophylaxis

1999 • 126 citations

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

2004 • 120 citations

Hepatitis B virus reactivation and alemtuzumab therapy

2005 • 119 citations

Frequency and type of serious infections in fludarabine‐refractory B‐cell chronic lymphocytic leukemia and small lymphocytic lymphoma

2002 • 117 citations

Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections

2000 • 115 citations

Campath‐1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

1995 • 103 citations

Management Guidelines for Use of Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia

2004 • 101 citations

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

1999 • 97 citations

Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma

1999 • 96 citations

Epstein–Barr Virus-Positive B-Cell Lymphoproliferative Disorders Arising in Immunodeficient Patients Previously Treated With Fludarabine for Low-Grade B-Cell Neoplasms

2002 • 90 citations

Infectious Complications of Human T Cell Leukemia/Lymphoma Virus Type I Infection

1996 • 88 citations

Prophylactic Measures in the Solid‐Organ Recipient before Transplantation

2001 • 85 citations

Hepatitis B Virus Reactivation in a Case of Non-Hodgkin's Lymphoma Treated with Chemotherapy and Rituximab: Necessity of Prophylaxis for Hepatitis B Virus Reactivation in Rituximab Therapy

2003 • 77 citations

Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.

2004 • 77 citations

Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas.

1994 • 77 citations

Septicemic complications of the cutaneous T-cell lymphomas

1981 • 71 citations

Cytomegalovirus Viremia During Campath-1H Therapy for Relapsed and Refractory Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia

2002 • 69 citations

Alemtuzumab in T-Cell Malignancies

2002 • 66 citations

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia

2003 • 65 citations

Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7–20 years after resettlement in Australia

2002 • 56 citations

The changing face of invasive fungal infections in hematopoietic cell transplant recipients

2005 • 56 citations

Prevention of opportunistic infections in immunosuppressed patients in the tropical top end of the Northern Territory.

2003 • 45 citations

Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up.

1993 • 44 citations

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia

2005 • 40 citations

Infectious Complications of Cutaneous T-Cell Lymphoma

2001 • 39 citations

Fatal Adenovirus Infection During Alemtuzumab (Anti-CD52 Monoclonal Antibody) Treatment of a Patient with Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

2002 • 35 citations

Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T‐cell lymphoproliferative disorders

2005 • 35 citations

A new model for predicting infectious complications during fludarabine‐based combination chemotherapy among patients with indolent lymphoid malignancies

2004 • 31 citations

Tuberculosis Due to Mycobacterium bovis after Alemtuzumab Administration

2003 • 30 citations

Efficacy and Tolerability of Alemtuzumab (CAMPATH-1H) in the Salvage Treatment of B-Cell Chronic Lymphocytic Leukemia—Change of Regimen Needed?

2003 • 30 citations

Toxoplasma gondii infection in patients with hematological malignancies

2004 • 25 citations

Management of Infection in Oncology Patients

2003 • 25 citations

Cutaneous T‐cell lymphoma

1997 • 18 citations

Combination Chemotherapy with Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Induces a High Response Rate in Previously Untreated CLL.

2005 • 17 citations

Immunological Effects and Safe Administration of Alemtuzumab (MabCampath™) in Advanced B-CLL

2002 • 14 citations

Alemtuzumab: effective monotherapy for simultaneous B‐cell chronic lymphocytic leukaemia and Sézary syndrome

2004 • 14 citations

Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infection

2003 • 14 citations

Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab

2003 • 13 citations

Pulmonary Nocardiosis with Bilateral Diffuse Granular Lung Shadows in a Patient with Subcutaneous Panniculitic T-cell Lymphoma.

2002 • 7 citations

Respiratory viruses in immunocompromised hosts Laurent Kaiser

2003 • 7 citations

Incidence, Natural History and Management of Cytomegalovirus (CMV) Dnaemia and Disease in Patients with Haematological Malignancies in the Non-Allogeneic Transplantation Setting.

2004 • 1 citations

Invasive aspergillosis complicating neoplastic diseases and hematopoietic stem cell transplantation Thomas J Walsh and Kieren A Marr

2003 • 1 citations

Deleted Work

1955 • 0 citations